Safety and Recipient Satisfaction of Propofol Sedation in Outpatient Endoscopy: A 24-Hour Prospective Investigation Using a Questionnaire Survey
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The aim of this study was to evaluate the safety of sedation with propofol as an alternative to benzodiazepinedrugs in outpatient endoscopy. Methods: In this prospective study, examinees who underwent outpatient endoscopy under propofol sedation and submitted a nextdayquestionnaire with providing informed consent were evaluated. Periprocedural acute responses, late adverse events within 24hours, and examinee satisfaction were evaluated. Results: Among the 4,122 patients who received propofol in the 17,978 outpatient-based endoscopic examinations performedbetween November 2016 and March 2018, 2,305 eligible examinees (esophagogastroduodenoscopy for 1,340, endoscopicultrasonography for 945, and total colonoscopy for 20) were enrolled, and their responses to a questionnaire were analyzed. Themean propofol dose was 69.6±24.4 mg (range, 20–200 mg). Diazepam, midazolam, and/or pentazocine in combination withpropofol was administered to 146 examinees. Mild oxygen desaturation was observed in 59 examinees (2.6%); and mild bradycardia,in 2 (0.09%). Other severe reactions or late events did not occur. After eliminating 181 invalid responses, 97.7% (2,065/2,124) of thepatients desired propofol sedation in future examinations. Conclusions: Propofol sedation was found to be safe-without severe adverse events or accidents-for outpatient endoscopy on thebasis of the patients’ next-day self-evaluation. Given the high satisfaction level, propofol sedation might be an ideal tool for painlessendoscopic screening.
Abstract
Background/Aims: The aim of this study was to evaluate the safety of sedation with propofol as an alternative to benzodiazepinedrugs in outpatient endoscopy. Methods: In this prospective study, examinees who underwent outpatient endoscopy under propofol sedation and submitted a nextdayquestionnaire with providing informed consent were evaluated. Periprocedural acute responses, late adverse events within 24hours, and examinee satisfaction were evaluated. Results: Among the 4,122 patients who received propofol in the 17,978 outpatient-based endoscopic examinations performedbetween November 2016 and March 2018, 2,305 eligible examinees (esophagogastroduodenoscopy for 1,340, endoscopicultrasonography for 945, and total colonoscopy for 20) were enrolled, and their responses to a questionnaire were analyzed. Themean propofol dose was 69.6±24.4 mg (range, 20–200 mg). Diazepam, midazolam, and/or pentazocine in combination withpropofol was administered to 146 examinees. Mild oxygen desaturation was observed in 59 examinees (2.6%); and mild bradycardia,in 2 (0.09%). Other severe reactions or late events did not occur. After eliminating 181 invalid responses, 97.7% (2,065/2,124) of thepatients desired propofol sedation in future examinations. Conclusions: Propofol sedation was found to be safe-without severe adverse events or accidents-for outpatient endoscopy on thebasis of the patients’ next-day self-evaluation. Given the high satisfaction level, propofol sedation might be an ideal tool for painlessendoscopic screening.
참고문헌 (15)
- Delgado AAA, "Propofol vs traditional sedatives for sedation in endoscopy : a systematic review and meta-analysis", World J Gastrointest Endosc, 11, pp.573~588 (2019)
- Grant SA, "Blood propofol concentration and psychomotor effects on driving skills", Br J Anaesth, 85, pp.396~400 (2000)
- Riphaus A, "Quality of psychomotor recovery after propofol sedation for routine endoscopy : a randomized and controlled study", Endoscopy, 38, pp.677~683 (2006)
- Basavana Goudra, "Association between Type of Sedation and the Adverse Events Associated with Gastrointestinal Endoscopy: An Analysis of 5 Years’ Data from a Tertiary Center in the USA", Clinical Endoscopy, 50(2), pp.161~169 (2017), 대한소화기내시경학회
- Hermanus H. B. Vaessen, "Considerable Variability of Procedural Sedation and Analgesia Practices for Gastrointestinal Endoscopic Procedures in Europe", Clinical Endoscopy, 49(1), pp.47~55 (2016), 대한소화기내시경학회
- 오지은, "Propofol versus Midazolam for Sedation during Esophagogastroduodenoscopy in Children", Clinical Endoscopy, 46(4), pp.368~372 (2013), 대한소화기내시경학회
- Horiuchi A, "Psychomotor recovery and blood propofol level in colonoscopy when using propofol sedation", Gastrointest Endosc, 75, pp.506~512 (2012)
- Horiuchi A, "Low-dose propofol sedation for diagnostic esophagogastroduodenoscopy : results in 10, 662 adults", Am J Gastroenterol, 104, pp.1650~1655 (2009)
- Horiuchi A, "Safety and effectiveness of propofol sedation during and after outpatient colonoscopy", World J Gastroenterol, 18, pp.3420~3425 (2012)
- Sipe BW, "Propofol versus midazolam", meperidine for outpatient colonoscopy : administration by nurses supervised by endoscopists, 2002, pp.55, 815~825
- Ulmer BJ, "Propofol versus midazolam", fentanyl for outpatient colonoscopy : administration by nurses supervised by endoscopists, 2003, pp.1, 425~432
- Dewitt J, "Nurse-administered propofol sedation compared with midazolam and meperidine for EUS : a prospective, randomized trial", Gastrointest Endosc, 68, pp.499~509 (2008)
- Vargo JJ, "Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy : a prospective, randomized trial", Gastroenterology, 123, pp.8~16 (2002)
- Riphaus A, "Sedation with propofol for routine ERCP in high-risk octogenarians : a randomized, controlled study", Am J Gastroenterol, 100, pp.1957~1963 (2005)
- Schilling D, "Sedation with propofol for interventional endoscopy by trained nurses in high-risk octogenarians : a prospective, randomized, controlled study", Endoscopy, 41, pp.295~298 (2009)